Baxter Cash on Hand 2010-2025 | BAX

Baxter cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Baxter cash on hand for the quarter ending June 30, 2025 was $1.686B, a 19.52% decline year-over-year.
  • Baxter cash on hand for 2024 was $1.764B, a 42.69% decline from 2023.
  • Baxter cash on hand for 2023 was $3.078B, a 79.16% increase from 2022.
  • Baxter cash on hand for 2022 was $1.718B, a 41.78% decline from 2021.
Baxter Annual Cash on Hand
(Millions of US $)
2024 $1,764
2023 $3,078
2022 $1,718
2021 $2,951
2020 $3,730
2019 $3,335
2018 $1,838
2017 $3,394
2016 $2,801
2015 $7,361
2014 $2,925
2013 $2,733
2012 $3,270
2011 $2,905
2010 $2,685
2009 $2,786
Baxter Quarterly Cash on Hand
(Millions of US $)
2025-06-30 $1,686
2025-03-31 $2,294
2024-12-31 $1,764
2024-09-30 $1,420
2024-06-30 $2,095
2024-03-31 $3,026
2023-12-31 $3,078
2023-09-30 $5,788
2023-06-30 $1,722
2023-03-31 $1,673
2022-12-31 $1,718
2022-09-30 $1,601
2022-06-30 $1,852
2022-03-31 $2,294
2021-12-31 $2,951
2021-09-30 $3,258
2021-06-30 $3,136
2021-03-31 $3,182
2020-12-31 $3,730
2020-09-30 $4,359
2020-06-30 $4,085
2020-03-31 $4,110
2019-12-31 $3,335
2019-09-30 $3,009
2019-06-30 $2,925
2019-03-31 $1,908
2018-12-31 $1,838
2018-09-30 $2,860
2018-06-30 $2,857
2018-03-31 $2,947
2017-12-31 $3,394
2017-09-30 $3,517
2017-06-30 $3,817
2017-03-31 $2,858
2016-12-31 $2,801
2016-09-30 $2,597
2016-06-30 $2,630
2016-03-31 $3,443
2015-12-31 $7,361
2015-09-30 $6,126
2015-06-30 $6,680
2015-03-31 $2,530
2014-12-31 $2,925
2014-09-30 $2,078
2014-06-30 $1,866
2014-03-31 $2,049
2013-12-31 $2,733
2013-09-30 $2,376
2013-06-30 $5,989
2013-03-31 $2,689
2012-12-31 $3,270
2012-09-30 $3,191
2012-06-30 $2,353
2012-03-31 $2,272
2011-12-31 $2,905
2011-09-30 $2,338
2011-06-30 $2,018
2011-03-31 $2,168
2010-12-31 $2,685
2010-09-30 $2,788
2010-06-30 $2,300
2010-03-31 $2,673
2009-12-31 $2,786
2009-09-30 $2,571
2009-06-30 $1,802
2009-03-31 $1,703
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.584B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.027B 26.85
Boston Scientific (BSX) United States $157.644B 37.59
Stryker (SYK) United States $150.755B 30.69
EssilorLuxottica (ESLOY) France $144.001B 0.00
Medtronic (MDT) Ireland $118.256B 16.67
Lonza Group Ag (LZAGY) Switzerland $50.628B 0.00
Haleon (HLN) United Kingdom $43.188B 24.69
ResMed (RMD) United States $41.753B 29.86
GE HealthCare Technologies (GEHC) United States $33.827B 15.90
Agilent Technologies (A) United States $33.605B 21.91
Koninklijke Philips (PHG) Netherlands $26.779B 17.71
Terumo (TRUMY) Japan $26.532B 31.44
Insulet (PODD) United States $23.358B 78.26
Zimmer Biomet Holdings (ZBH) United States $21.303B 13.56
Smith & Nephew SNATS (SNN) United Kingdom $16.337B 0.00
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.027B 29.48
Lantheus Holdings (LNTH) United States $3.785B 10.23
Envista Holdings (NVST) United States $3.513B 24.58
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.268B 14.50
Perrigo (PRGO) Ireland $3.265B 8.15
ICU Medical (ICUI) United States $3.109B 21.17
Haemonetics (HAE) United States $2.661B 11.88
LeMaitre Vascular (LMAT) United States $2.157B 46.25
Acuren (TIC) United States $2.156B 0.00
Curaleaf Holdings (CURLF) Canada $2.117B 0.00
QuidelOrtho (QDEL) United States $1.896B 11.93
Green Thumb Industries (GTBIF) United States $1.888B 81.09
AtriCure (ATRC) United States $1.882B 0.00
Tilray Brands (TLRY) Canada $1.596B 0.00
Phibro Animal Health (PAHC) United States $1.323B 16.91
AdaptHealth (AHCO) United States $1.246B 17.71
BioLife Solutions (BLFS) United States $1.229B 2565.00
Neogen (NEOG) United States $1.223B 19.41
Kestra Medical Technologies (KMTS) United States $0.952B 0.00
InMode (INMD) Israel $0.941B 8.70
Valneva SE (VALN) France $0.762B 0.00
Cresco Labs (CRLBF) United States $0.683B 0.00
SNDL (SNDL) Canada $0.649B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.535B 20.62
Surmodics (SRDX) United States $0.496B 0.00
Evolus (EOLS) United States $0.495B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.11
CeriBell (CBLL) United States $0.420B 0.00
Owens & Minor (OMI) United States $0.387B 3.43
Sanuwave Health (SNWV) United States $0.360B 0.00
Canopy Growth (CGC) Canada $0.353B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Brainsway (BWAY) Israel $0.301B 61.15
Sanara MedTech (SMTI) United States $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.299B 0.00
Omeros (OMER) United States $0.298B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
High Tide (HITI) Canada $0.283B 0.00
Viemed Healthcare (VMD) United States $0.273B 20.74
Cerus (CERS) United States $0.255B 0.00
OraSure Technologies (OSUR) United States $0.255B 0.00
TriSalus Life Sciences (TLSI) United States $0.254B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Organigram Global (OGI) Canada $0.221B 0.00
Quanterix (QTRX) United States $0.218B 0.00
Exagen (XGN) United States $0.218B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.24
FitLife Brands (FTLF) United States $0.173B 21.31
Biote (BTMD) United States $0.164B 5.43
Jushi Holdings (JUSHF) United States $0.151B 0.00
Jin Medical (ZJYL) China $0.130B 0.00
MacroGenics (MGNX) United States $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 12.32
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.068B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 32.90
Veru (VERU) United States $0.051B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.043B 33.67
Rockwell Medical (RMTI) United States $0.043B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 14.62
Trinity Biotech (TRIB) Ireland $0.027B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00